Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering
12 pending office actions • 12 art units • 12 examiners • 0 of 12 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
The University of Queensland has 10 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 10 distinct examiners and 10 distinct art units, indicating that the portfolio's activity is fully distributed across the recorded examination assignments.
KELLY, ROBERT M is the busiest examiner, with 1 pending matter. No examiner has a larger recorded concentration, so portfolio management should rely on application-specific preparation rather than a single examiner playbook.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (8%) |
| §101 + other | 3 (25%) |
| §103 only | 1 (8%) |
| §102 only | 2 (17%) |
| §112 only | 1 (8%) |
| Multi-statute (no §101) | 4 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KELLY, ROBERT M | 1 | 74.1% | +24.1% |
| MAUPIN, HUGH H | 1 | 87.5% | +6.3% |
| TRAN, KHOA NHAT | 1 | 41.9% | +50.5% |
| MCGUIRK, JOHN SCHUYLER | 1 | 77.8% | +49.3% |
| WECKER, JENNIFER | 1 | 70.9% | +36.6% |
| LI, AIQUN | 1 | 63.7% | +23.1% |
| BOHATY, ANDREW K | 1 | 65.7% | +23.1% |
| MERCIER, MELISSA S | 1 | 72.1% | +5.8% |
| BOSWORTH, KAMI A | 1 | 69.1% | +28.6% |
| SANG, HONG | 1 | 54.9% | +62.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17286220 | A METHOD AND APPARATUS FOR DIAGNOSIS OF MALADIES FROM PATIENT SOUNDS | MELHUS, BENJAMIN S | 308d overdue |
| 18757662 | Renal Progenitor Cells | TRAN, KHOA NHAT | 25d overdue |
| 18872451 | A Cell Surface Marker Signature for Arrhythmogenic Pluripotent Stem Cell-Derived Cardiomyocytes | KELLY, ROBERT M | — |
| 18914388 | DETECTION METHOD | MAUPIN, HUGH H | — |
| 18562197 | RAPID MEASUREMENT OF COAL OXIDATION | MCGUIRK, JOHN SCHUYLER | — |
| 18254569 | GRAPHENE PROCESSING TECHNIQUE | LI, AIQUN | — |
| 18247963 | TRIPLET QUENCHING | BOHATY, ANDREW K | — |
| 18023274 | SOL-GEL COMPOSITION | MERCIER, MELISSA S | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18757662 | Renal Progenitor Cells | TRAN, KHOA NHAT | 25d overdue |
| 18872451 | A Cell Surface Marker Signature for Arrhythmogenic Pluripotent Stem Cell-Derived Cardiomyocytes | KELLY, ROBERT M | — |
| 18562197 | RAPID MEASUREMENT OF COAL OXIDATION | MCGUIRK, JOHN SCHUYLER | — |
| 18552340 | METHOD OF DETECTION | WECKER, JENNIFER | — |
| 18254569 | GRAPHENE PROCESSING TECHNIQUE | LI, AIQUN | — |
| 18247963 | TRIPLET QUENCHING | BOHATY, ANDREW K | — |
| 17782159 | TREATMENT OF NEURODEGENERATIVE DISEASES USING ULTRASOUND AND AMYLOID-BETA ANTIBODIES | BOSWORTH, KAMI A | — |
| 17774796 | BINDING PROTEINS TO CUB DOMAIN-CONTAINING PROTEIN (CDCP1) | SANG, HONG | — |
| Art Unit | Apps |
|---|---|
| 1638 | 1 |
| 2884 | 1 |
| 1632 | 1 |
| 1798 | 1 |
| 1796 | 1 |
| 1766 | 1 |
| 1759 | 1 |
| 1615 | 1 |
| 3783 | 1 |
| 1646 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18872451 | A Cell Surface Marker Signature for Arrhythmogenic Pluripotent Stem Cell-Derived Cardiomyocytes | KELLY, ROBERT M | 1638 | §101§102§112 | Non-Final OA | — | Pending | Dec 06, 2024 |
| 18914388 | DETECTION METHOD | MAUPIN, HUGH H | 2884 | §102§103 | Non-Final OA | — | Pending | Oct 14, 2024 |
| 18757662 | Renal Progenitor Cells | TRAN, KHOA NHAT | 1632 | §102§103Other | Final Rejection | 25d overdue | Pending | Jun 28, 2024 |
| 18562197 | RAPID MEASUREMENT OF COAL OXIDATION | MCGUIRK, JOHN SCHUYLER | 1798 | §101§102§103 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18552340 | METHOD OF DETECTION | WECKER, JENNIFER | 1796 | §102 | Non-Final OA | — | Pending | Sep 25, 2023 |
| 18254569 | GRAPHENE PROCESSING TECHNIQUE | LI, AIQUN | 1766 | §102§112 | Final Rejection | — | Pending | May 25, 2023 |
| 18247963 | TRIPLET QUENCHING | BOHATY, ANDREW K | 1759 | §101§102§103 | Non-Final OA | — | Pending | Apr 05, 2023 |
| 18023274 | SOL-GEL COMPOSITION | MERCIER, MELISSA S | 1615 | §102§103§112 | Non-Final OA | — | Pending | Feb 24, 2023 |
| 17782159 | TREATMENT OF NEURODEGENERATIVE DISEASES USING ULTRASOUND AND AMYLOID-BETA ANTIBODIES | BOSWORTH, KAMI A | 3783 | §103 | Non-Final OA | — | Pending | Jun 02, 2022 |
| 17774796 | BINDING PROTEINS TO CUB DOMAIN-CONTAINING PROTEIN (CDCP1) | SANG, HONG | 1646 | §102 | Non-Final OA | — | Pending | May 05, 2022 |
| 17433949 | ACOUSTIC ENERGY TREATMENT | MOHAMMED, SHAHDEEP | 3797 | §112 | Non-Final OA | 30d overdue | Pending | Aug 25, 2021 |
| 17286220 | A METHOD AND APPARATUS FOR DIAGNOSIS OF MALADIES FROM PATIENT SOUNDS | MELHUS, BENJAMIN S | 3791 | §101 | Final Rejection | 308d overdue | Pending | Apr 16, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe University of Queensland has 12 pending office actions as of October 2026, spread across 12 art units and 12 examiners.
Robert M Kelly has the most, with 1 of The University of Queensland's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
